HCA
KYMR icon

Harbor Capital Advisors’s Kymera Therapeutics KYMR Stock Holding History

Harbor Capital Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.17M Buy
36,368
+2,420
+7% +$208K 0.28% 81
2026
Q1 		$2.83M Buy
33,948
+3,375
+11% +$267K 0.23% 114
2025
Q4 		$2.38M Buy
30,573
+645
+2% +$43.6K 0.18% 144
2025
Q3 		$1.69M Sell
29,928
-3,544
-11% -$160K 0.13% 206
2025
Q2 		$1.46M Buy
33,472
+2,594
+8% +$89.3K 0.06% 377
2025
Q1 		$845K Sell
30,878
-10,109
-25% -$369K 0.04% 461
2024
Q4 		$1.65M Buy
40,987
+684
+2% +$30.9K 0.07% 346
2024
Q3 		$1.91M Buy
40,303
+9,292
+30% +$410K 0.08% 309
2024
Q2 		$926K Sell
31,011
-10,321
-25% -$357K 0.07% 378
2024
Q1 		$1.66M Buy
41,332
+6,691
+19% +$239K 0.22% 110
2023
Q4 		$882K Sell
34,641
-570
-2% -$10.2K 0.17% 155
2023
Q3 		$489K Buy
35,211
+3,834
+12% +$77.1K 0.1% 231
2023
Q2 		$721K Buy
31,377
+20,059
+177% +$575K 0.14% 185
2023
Q1 		$335K Sell
11,318
-360
-3% -$11.6K 0.1% 175
2022
Q4 		$291K Sell
11,678
-247
-2% -$6.59K 0.28% 73
2022
Q3 		$260K Sell
11,925
-340
-3% -$8.96K 0.24% 77
2022
Q2 		$241K Sell
12,265
-1,730
-12% -$40.4K 0.18% 79
2022
Q1 		$592K Sell
13,995
-2,856
-17% -$121K 0.28% 75
2021
Q4 		$1.07M Buy
+16,851
New +$981K 0.39% 69

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Harbor Capital Advisors's KYMR Position: Q2 2026 in Review

Harbor Capital Advisors increased its Kymera Therapeutics (KYMR) stake by 7.1% in Q2 2026, buying an estimated $208K and bringing the position to 36,368 shares worth $4.17M. The position accounts for 0.28% of the portfolio, ranked #81.

Harbor Capital Advisors first reported a position in KYMR in Q4 2021 and has held it in 19 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Harbor Capital Advisors held 36,368 shares of Kymera Therapeutics worth $4.17M as of Q2 2026.
  • Harbor Capital Advisors bought 2,420 Kymera Therapeutics shares in Q2 2026, an estimated $208K.
  • Kymera Therapeutics made up 0.28% of Harbor Capital Advisors's portfolio in Q2 2026, its #81 holding.
  • Harbor Capital Advisors first reported a position in Kymera Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.